XML 46 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Acquisitions and Divestitures (Tables)
9 Months Ended
Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Noncash or Part Noncash Acquisitions
During the nine months ended September 30, 2024 the Company acquired dialysis businesses as follows:
Nine months ended September 30, 2024
Cash paid, net of cash acquired$161,210 
Contingent earn-out obligations$296 
Liabilities assumed$54,033 
Fair value of previously held equity method investments$67,526 
Number of dialysis centers acquired — U.S.12 
Number of dialysis centers acquired — International91 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:
Nine months ended September 30, 2024
Current assets$150,907 
Property and equipment46,738 
Right-of-use lease assets and other long-term assets51,491 
Indefinite-lived licenses10,722 
Goodwill139,606 
Liabilities assumed(96,141)
Noncontrolling interests assumed(20,258)
$283,065